Discover
SGP
SpyGlass Pharma, Inc. Common Stock
20.07
3 x 20.08
1 x 20.27
bid
ask
-
0.20
0.99%
12:02 PM
timesize
| Ytd | -23.98% | |
| 1y | -23.98% |
19.98
day range
20.81
17.06
52 week range
32.44
| Open | 20.22 | Prev Close | 20.27 | Low | 19.98 | High | 20.81 | Mkt Cap | 677.69M |
| Vol | 26.58K | Avg Vol | 109.59K | EPS | -6.41 | P/E | -3.16 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 20.26 | 200-d Avg | 23.20 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 15.41M | ||
| Research and Development Expense | 8.54M | ||
| Selling, General and Administrative Expense | 6.87M | ||
| Operating Income | -15.41M | ||
| Net Income | -13.82M | ||
| Net Income Common Stock | -13.82M | ||
| Net Income Common Stock (USD) | -13.82M | ||
| Consolidated Income | -13.82M | ||
| Earnings per Basic Share | -0.69 | ||
| Earnings per Basic Share (USD) | -0.69 | ||
| Earnings per Diluted Share | -0.69 | ||
| Earning Before Interest & Taxes (EBIT) | -13.82M | ||
| Earning Before Interest & Taxes (USD) | -13.82M | ||
| Weighted Average Shares | 19.93M | ||
| Weighted Average Shares Diluted | 19.93M | ||
| Balance Sheet | |||
| Cash and Equivalents | 238.90M | ||
| Cash and Equivalents (USD) | 238.90M | ||
| Investments | 12.10M | ||
| Investments Current | 12.10M | ||
| Trade and Non-Trade Receivables | 653.00K | ||
| Current Assets | 253.36M | ||
| Property, Plant & Equipment Net | 4.24M | ||
| Total Assets | 258.39M | ||
| Total Debt | 1.61M | ||
| Current Liabilities | 6.67M | ||
| Debt Non-Current | 1.61M | ||
| Total Liabilities | 8.27M | ||
| Accumulated Retained Earnings (Deficit) | -118.55M | ||
| Shareholders Equity | 250.11M | ||
| Shareholders Equity (USD) | 250.11M | ||
| Assets Non-Current | 5.02M | ||
| Total Debt (USD) | 1.61M | ||
| Liabilities Non-Current | 1.61M | ||
| Trade and Non-Trade Payables | 3.51M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 381.00K | ||
| Net Cash Flow from Financing | 157.76M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 142.54M | ||
| Capital Expenditure | -676.00K | ||
| Issuance (Purchase) of Equity Shares | 160.48M | ||
| Net Cash Flow from Investing | -1.67M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -991.00K | ||
| Net Cash Flow from Operations | -13.54M | ||
| Share Based Compensation | 1.68M | ||